AMPHOTERICIN B

AMPHOTERICIN B was reported 12863 times

AMPHOTERICIN B is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERMITTENT POSITIVE PRESSURE BREATHING 10 0.7143
1 VASCULAR ANASTOMOTIC HAEMORRHAGE 20 0.6667
2 B SYMPTOMS 10 0.3846
3 BRONCHIAL ANASTOMOSIS COMPLICATION 9 0.3750
4 VENA CAVA INJURY 26 0.2826
5 PYELONEPHRITIS FUNGAL 17 0.2297
6 PROTOTHECOSIS 21 0.2234
7 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV 10 0.2222
8 PERINEAL CYST 16 0.2192
9 CHOROIDITIS 72 0.1925
10 FOETAL ANAEMIA 25 0.1908
11 HEPATOSPLENIC CANDIDIASIS 26 0.1769
12 DIAPHRAGMATIC INJURY 12 0.1622
13 DISSEMINATED MUCORMYCOSIS 63 0.1599
14 FUNGAL DISEASE CARRIER 16 0.1584
15 FUNGAL ENDOCARDITIS 46 0.1528
16 DISSEMINATED COCCIDIOIDOMYCOSIS 20 0.1418
17 RHINOCEREBRAL MUCORMYCOSIS 49 0.1412
18 SERRATIA SEPSIS 15 0.1389
19 FUSARIUM INFECTION 96 0.1371
20 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 31 0.1336
21 CEREBRAL ASPERGILLOSIS 79 0.1285
22 RENAL CYST HAEMORRHAGE 29 0.1283
23 INTRACRANIAL INFECTION 16 0.1280
24 GEOTRICHUM INFECTION 27 0.1280
25 BLOOD IMMUNOGLOBULIN M ABNORMAL 13 0.1262
26 DISSEMINATED TRICHOSPORONOSIS 9 0.1250
27 TRICHOSPORON INFECTION 49 0.1210
28 OSTEOMYELITIS FUNGAL 20 0.1198
29 ENDOCARDITIS CANDIDA 9 0.1184
30 FLUOROSIS 10 0.1163
31 PULMONARY MUCORMYCOSIS 60 0.1136
32 PERICORONITIS 10 0.1099
33 SCEDOSPORIUM INFECTION 77 0.1091
34 CEREBRAL VENTRICLE COLLAPSE 8 0.1067
35 DISSEMINATED BLASTOMYCOSIS 18 0.1053
36 PERINEPHRIC ABSCESS 16 0.1053
37 SPLENIC EMBOLISM 12 0.1043
38 DISSEMINATED ASPERGILLOSIS 49 0.1038
39 MUCORMYCOSIS 263 0.1011
40 DEHISCENCE 18 0.0952
41 CONGENITAL PNEUMONIA 9 0.0947
42 EYE INFECTION FUNGAL 35 0.0904
43 EMPHYSEMATOUS PYELONEPHRITIS 16 0.0874
44 CRYPTOCOCCAL MENINGOENCEPHALITIS 11 0.0840
45 KERATITIS FUNGAL 17 0.0817
46 MENINGITIS CRYPTOCOCCAL 141 0.0806
47 ABSCESS FUNGAL 14 0.0800
48 SIDEROBLASTIC ANAEMIA 11 0.0786
49 URINARY TRACT CANDIDIASIS 15 0.0785
50 BLOOD IMMUNOGLOBULIN G ABNORMAL 13 0.0778
51 CRYPTOCOCCAL CUTANEOUS INFECTION 14 0.0769
52 LEISHMANIASIS 22 0.0759
53 MUCOCUTANEOUS LEISHMANIASIS 9 0.0738
54 ABDOMINAL WALL HAEMORRHAGE 19 0.0728
55 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 22 0.0726
56 GASTROINTESTINAL MUCORMYCOSIS 12 0.0719
57 DISSEMINATED CRYPTOCOCCOSIS 54 0.0713
58 PARASPINAL ABSCESS 11 0.0710
59 CUTANEOUS MUCORMYCOSIS 13 0.0707
60 VARICELLA VIRUS TEST POSITIVE 12 0.0706
61 ADENOVIRUS REACTIVATION 10 0.0694
62 MYCOTIC ENDOPHTHALMITIS 13 0.0688
63 CRYPTOCOCCOSIS 109 0.0668
64 FUNGAEMIA 101 0.0641
65 VISCERAL LEISHMANIASIS 46 0.0637
66 ASPERGILLOSIS 80 0.0612
67 GINGIVITIS ULCERATIVE 13 0.0605
68 ZYGOMYCOSIS 27 0.0577
69 VASCULAR COMPRESSION 18 0.0570
70 ASPERGILLUS INFECTION 363 0.0553
71 PERIVENTRICULAR LEUKOMALACIA 15 0.0530
72 SYSTEMIC MYCOSIS 61 0.0522
73 CEREBRAL FUNGAL INFECTION 14 0.0495
74 CANDIDA SEPSIS 42 0.0468
75 SYSTEMIC CANDIDA 114 0.0454
76 DELAYED GRAFT FUNCTION 32 0.0450
77 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 15 0.0448
78 UREAPLASMA INFECTION 18 0.0441
79 VITAMIN B1 DECREASED 11 0.0438
80 MORAXELLA INFECTION 12 0.0438
81 BLASTOMYCOSIS 21 0.0432
82 IMMUNE RECONSTITUTION SYNDROME 55 0.0426
83 BRONCHOPULMONARY ASPERGILLOSIS 321 0.0414
84 CARDIAC VALVE VEGETATION 20 0.0412
85 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 9 0.0407
86 BLOOD BETA-D-GLUCAN INCREASED 12 0.0391
87 FUNGAL SEPSIS 32 0.0385
88 SEPTIC EMBOLUS 32 0.0385
89 PNEUMONIA CRYPTOCOCCAL 36 0.0381
90 HISTOPLASMOSIS DISSEMINATED 60 0.0378
91 INTRAOCULAR PRESSURE TEST 9 0.0375
92 ASPERGILLOMA 12 0.0375
93 PERIOSTITIS 16 0.0370
94 CITROBACTER INFECTION 15 0.0350
95 POSITIVE AIRWAY PRESSURE THERAPY 10 0.0342
96 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 12 0.0342
97 LOWER RESPIRATORY TRACT INFECTION FUNGAL 13 0.0334
98 NECROTISING RETINITIS 21 0.0328
99 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 161 0.0323
100 PULMONARY NECROSIS 11 0.0323
101 VESICOURETERIC REFLUX 13 0.0321
102 INFECTION IN AN IMMUNOCOMPROMISED HOST 23 0.0320
103 BLOOD URIC ACID ABNORMAL 13 0.0319
104 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 9 0.0310
105 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 66 0.0310
106 IDIOPATHIC PNEUMONIA SYNDROME 9 0.0302
107 CHOLANGITIS INFECTIVE 8 0.0301
108 CAROTID ARTERIOSCLEROSIS 31 0.0300
109 EYE ABSCESS 9 0.0295
110 NAIL BED INFLAMMATION 9 0.0282
111 SERRATIA INFECTION 21 0.0282
112 SINUSITIS FUNGAL 22 0.0274
113 DELIVERY 18 0.0273
114 WHITE MATTER LESION 33 0.0261
115 ASPERGILLUS TEST POSITIVE 8 0.0260
116 PNEUMONIA FUNGAL 102 0.0258
117 LUNG TRANSPLANT REJECTION 17 0.0258
118 CENTRAL NERVOUS SYSTEM VASCULITIS 13 0.0255
119 INTERLEUKIN LEVEL INCREASED 14 0.0254
120 BRAIN ABSCESS 64 0.0253
121 NEPHROGENIC DIABETES INSIPIDUS 29 0.0251
122 INTERVERTEBRAL DISC SPACE NARROWING 20 0.0248
123 RETINAL ISCHAEMIA 15 0.0245
124 CNS VENTRICULITIS 8 0.0245
125 CORYNEBACTERIUM INFECTION 13 0.0243
126 RECTAL PROLAPSE 29 0.0240
127 BLOOD LACTATE DEHYDROGENASE ABNORMAL 16 0.0236
128 STENOTROPHOMONAS INFECTION 32 0.0236
129 AORTIC DILATATION 26 0.0234
130 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 14 0.0233
131 HEPATOSPLENOMEGALY 59 0.0230
132 RESPIRATORY TRACT INFECTION FUNGAL 12 0.0227
133 HISTOPLASMOSIS 40 0.0226
134 MEDIASTINITIS 13 0.0224
135 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 61 0.0220
136 ENGRAFTMENT SYNDROME 13 0.0220
137 RENAL ABSCESS 18 0.0220
138 BRONCHOSTENOSIS 12 0.0219
139 ACINETOBACTER INFECTION 24 0.0219
140 COCCIDIOIDOMYCOSIS 26 0.0218
141 ENDOPHTHALMITIS 126 0.0210
142 PHAEOHYPHOMYCOSIS 10 0.0209
143 ENTEROCOCCAL INFECTION 100 0.0207
144 PSEUDOMONAL SEPSIS 36 0.0205
145 ECTHYMA 8 0.0200
146 GRANULOMATOUS LIVER DISEASE 14 0.0199
147 RENAL ARTERY STENOSIS 27 0.0196
148 GRAFT VERSUS HOST DISEASE IN LIVER 14 0.0196
149 FEBRILE INFECTION 23 0.0195
150 COAGULATION TEST ABNORMAL 15 0.0195
151 ENTEROCOCCAL BACTERAEMIA 20 0.0189
152 PNEUMONIA NECROTISING 12 0.0185
153 NEPHROPATHY TOXIC 208 0.0185
154 CYTOMEGALOVIRUS ENTEROCOLITIS 14 0.0182
155 CHYLOTHORAX 13 0.0180
156 THYROXINE FREE DECREASED 10 0.0177
157 MARROW HYPERPLASIA 12 0.0176
158 CYTOMEGALOVIRUS TEST POSITIVE 31 0.0174
159 ABDOMINAL COMPARTMENT SYNDROME 11 0.0173
160 URINARY TRACT INFECTION ENTEROCOCCAL 16 0.0171
161 CHORIORETINITIS 11 0.0171
162 DYSBIOSIS 14 0.0171
163 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 24 0.0170
164 MULTIPLE ORGAN DYSFUNCTION SYNDROME 480 0.0169
165 HYPOPROTEINAEMIA 32 0.0169
166 PULMONARY SEPSIS 24 0.0165
167 LIP EROSION 12 0.0164
168 PSEUDOMONAL BACTERAEMIA 14 0.0164
169 HAEMOPERITONEUM 13 0.0162
170 PULMONARY CAVITATION 14 0.0161
171 ACTINIC KERATOSIS 41 0.0158
172 MYCOBACTERIAL INFECTION 27 0.0157
173 VIRAL HAEMORRHAGIC CYSTITIS 11 0.0154
174 NASAL MUCOSAL DISORDER 9 0.0154
175 GRAFT VERSUS HOST DISEASE 111 0.0154
176 PATHOGEN RESISTANCE 139 0.0152
177 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 12 0.0152
178 LYMPHOCELE 10 0.0151
179 BRAIN HERNIATION 45 0.0151
180 INTRACRANIAL MASS 14 0.0148
181 PSEUDOMONAS TEST POSITIVE 12 0.0147
182 COMPLICATIONS OF TRANSPLANTED KIDNEY 33 0.0145
183 GRAFT VERSUS HOST DISEASE IN SKIN 32 0.0145
184 SYSTEMIC INFECTION 24 0.0145
185 MUSCLE ABSCESS 9 0.0144
186 KLEBSIELLA INFECTION 73 0.0144
187 PNEUMONIA PSEUDOMONAL 22 0.0143
188 TRACHEOBRONCHITIS 11 0.0143
189 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 107 0.0142
190 BACILLUS INFECTION 9 0.0142
191 PNEUMOCYSTIS JIROVECII INFECTION 17 0.0142
192 VARICELLA ZOSTER VIRUS INFECTION 29 0.0140
193 VENOOCCLUSIVE DISEASE 35 0.0140
194 BLADDER TRANSITIONAL CELL CARCINOMA 20 0.0140
195 CEREBRAL ARTERY EMBOLISM 17 0.0139
196 STREPTOCOCCAL BACTERAEMIA 15 0.0138
197 CORNEAL EPITHELIUM DEFECT 8 0.0138
198 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 32 0.0136
199 ENTEROCOCCAL SEPSIS 11 0.0136
200 NECROTISING COLITIS 17 0.0134
201 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 35 0.0131
202 DRUG RESISTANCE 337 0.0131
203 TOXOPLASMOSIS 14 0.0130
204 BACTERIAL SEPSIS 42 0.0129
205 CORNEAL PERFORATION 8 0.0127
206 NEUTROPENIC COLITIS 26 0.0126
207 PROTEUS INFECTION 9 0.0125
208 PNEUMONIA KLEBSIELLA 23 0.0125
209 RENAL TUBULAR DISORDER 35 0.0124
210 KLEBSIELLA SEPSIS 14 0.0124
211 IMMUNOGLOBULINS DECREASED 17 0.0124
212 PULMONARY GRANULOMA 14 0.0123
213 PSEUDOMONAS INFECTION 105 0.0122
214 STAPHYLOCOCCAL BACTERAEMIA 53 0.0122
215 INTESTINAL INFARCTION 11 0.0121
216 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 40 0.0121
217 AORTIC ARTERIOSCLEROSIS 31 0.0120
218 SPLENIC INFARCTION 21 0.0120
219 CANDIDA INFECTION 202 0.0119
220 TUMOUR PSEUDOPROGRESSION 13 0.0119
221 MEAN CELL VOLUME INCREASED 30 0.0117
222 NEUROLOGICAL DECOMPENSATION 27 0.0117
223 FUNGAL SKIN INFECTION 47 0.0116
224 CEREBRAL CYST 8 0.0116
225 CAPILLARY LEAK SYNDROME 24 0.0116
226 METAPNEUMOVIRUS INFECTION 9 0.0115
227 TRANSPLANT FAILURE 28 0.0114
228 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 15 0.0114
229 MULTIPLE-DRUG RESISTANCE 35 0.0113
230 APLASIA 22 0.0112
231 HAEMOPHILUS INFECTION 11 0.0112
232 MUCOSAL HAEMORRHAGE 13 0.0112
233 SPUTUM CULTURE POSITIVE 9 0.0111
234 MUCOSAL DISORDER 11 0.0111
235 ADENOVIRUS INFECTION 32 0.0110
236 BACTERIAL DISEASE CARRIER 8 0.0110
237 VENOOCCLUSIVE LIVER DISEASE 54 0.0109
238 B-CELL TYPE ACUTE LEUKAEMIA 8 0.0109
239 CHRONIC GRAFT VERSUS HOST DISEASE 39 0.0108
240 APLASTIC ANAEMIA 56 0.0107
241 ACUTE MYELOID LEUKAEMIA RECURRENT 23 0.0107
242 TOXIC EPIDERMAL NECROLYSIS 160 0.0105
243 SOFT TISSUE INFECTION 19 0.0104
244 DRUG LEVEL BELOW THERAPEUTIC 57 0.0103
245 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 98 0.0103
246 INTRACRANIAL PRESSURE INCREASED 57 0.0102
247 HAEMATOLOGICAL INFECTION 25 0.0102
248 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 39 0.0102
249 STREPTOCOCCAL SEPSIS 12 0.0101
250 HYPOFIBRINOGENAEMIA 10 0.0101
251 PULMONARY HAEMORRHAGE 77 0.0098
252 ACUTE GRAFT VERSUS HOST DISEASE 45 0.0098
253 MENINGITIS BACTERIAL 14 0.0098
254 BK VIRUS INFECTION 33 0.0098
255 CEREBRAL TOXOPLASMOSIS 9 0.0096
256 RENAL ATROPHY 12 0.0096
257 HISTIOCYTOSIS HAEMATOPHAGIC 28 0.0094
258 INFECTIOUS PLEURAL EFFUSION 14 0.0092
259 CYSTITIS HAEMORRHAGIC 37 0.0092
260 BRADYARRHYTHMIA 15 0.0091
261 CYTOMEGALOVIRUS INFECTION 151 0.0091
262 SMALL INTESTINAL PERFORATION 17 0.0091
263 SECONDARY IMMUNODEFICIENCY 11 0.0091
264 ENTEROBACTER INFECTION 15 0.0089
265 SEPTIC SHOCK 387 0.0089
266 LEUKAEMIA RECURRENT 15 0.0089
267 NECROSIS 49 0.0088
268 CENTRAL NERVOUS SYSTEM INFECTION 10 0.0087
269 CYTOMEGALOVIRUS INFECTION REACTIVATION 38 0.0086
270 INTERVERTEBRAL DISCITIS 16 0.0085
271 CANDIDIASIS 34 0.0085
272 ACUTE LUNG INJURY 10 0.0084
273 DEVICE RELATED SEPSIS 17 0.0084
274 ESCHERICHIA INFECTION 67 0.0081
275 STAPHYLOCOCCAL SKIN INFECTION 10 0.0081
276 PNEUMONIA PNEUMOCOCCAL 12 0.0081
277 VANISHING BILE DUCT SYNDROME 9 0.0081
278 HAEMOTHORAX 23 0.0079
279 H1N1 INFLUENZA 11 0.0078
280 GRANULOMA 27 0.0078
281 SPINAL STENOSIS 32 0.0077
282 FUNGAL INFECTION 258 0.0077
283 HYPERBILIRUBINAEMIA 80 0.0077
284 LEFT VENTRICULAR HYPERTROPHY 33 0.0077
285 HYDROCEPHALUS 42 0.0077
286 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 39 0.0077
287 DISSEMINATED INTRAVASCULAR COAGULATION 108 0.0077
288 ENCEPHALITIS 53 0.0077
289 OBLITERATIVE BRONCHIOLITIS 10 0.0076
290 BONE MARROW TOXICITY 9 0.0076
291 ACUTE ABDOMEN 11 0.0075
292 HUMAN HERPESVIRUS 6 INFECTION 14 0.0074
293 BENIGN PROSTATIC HYPERPLASIA 38 0.0074
294 STEROID DIABETES 11 0.0073
295 BRAIN OEDEMA 92 0.0073
296 OLIGURIA 45 0.0072
297 RHINOVIRUS INFECTION 28 0.0072
298 HYPERPARATHYROIDISM SECONDARY 18 0.0072
299 MULTI-ORGAN FAILURE 124 0.0072
300 TRANSPLANT REJECTION 57 0.0071
301 DIVERTICULUM INTESTINAL 31 0.0071
302 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 36 0.0071
303 RETINITIS 12 0.0069
304 ELECTROLYTE IMBALANCE 79 0.0068
305 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 12 0.0068
306 TRANSPLANT DYSFUNCTION 12 0.0067
307 HYPOKALAEMIA 309 0.0067
308 FEBRILE NEUTROPENIA 444 0.0067
309 BLOOD CULTURE POSITIVE 20 0.0067
310 LUNG ABSCESS 14 0.0067
311 CYTOMEGALOVIRUS CHORIORETINITIS 13 0.0067
312 INFLAMMATORY MARKER INCREASED 33 0.0067
313 SUSPECTED OFF LABEL USE 30 0.0066
314 PNEUMOMEDIASTINUM 12 0.0066
315 MUCOUS MEMBRANE DISORDER 9 0.0066
316 ESCHERICHIA SEPSIS 19 0.0065
317 EXOPHTHALMOS 14 0.0065
318 STAPHYLOCOCCAL SEPSIS 32 0.0065
319 AUTOIMMUNE HAEMOLYTIC ANAEMIA 22 0.0064
320 HYPERAMMONAEMIA 32 0.0064
321 LABELLED DRUG-DRUG INTERACTION ISSUE 9 0.0062
322 PNEUMONIA CYTOMEGALOVIRAL 12 0.0062
323 BACTERAEMIA 73 0.0061
324 SQUAMOUS CELL CARCINOMA OF SKIN 37 0.0061
325 LUNG CONSOLIDATION 17 0.0061
326 CYTOMEGALOVIRUS VIRAEMIA 27 0.0061
327 DRUG LEVEL DECREASED 61 0.0060
328 SKIN NECROSIS 31 0.0060
329 MUCOSAL INFLAMMATION 156 0.0060
330 CLOSTRIDIUM TEST POSITIVE 13 0.0059
331 ESCHERICHIA URINARY TRACT INFECTION 25 0.0059
332 BLADDER SPASM 11 0.0059
333 LIVER ABSCESS 19 0.0059
334 HYPERPARATHYROIDISM 12 0.0058
335 CORNEAL OEDEMA 13 0.0058
336 DRUG LEVEL INCREASED 96 0.0058
337 DERMATITIS EXFOLIATIVE 29 0.0058
338 HEPATOTOXICITY 129 0.0058
339 LUNG INFILTRATION 51 0.0058
340 IMPRISONMENT 10 0.0057
341 ENDOCARDITIS 29 0.0056
342 MIXED LIVER INJURY 17 0.0056
343 SCLERITIS 9 0.0056
344 PYELONEPHRITIS ACUTE 11 0.0056
345 ACUTE RESPIRATORY DISTRESS SYNDROME 99 0.0056
346 IMPLANT SITE INFECTION 13 0.0056
347 RESPIRATORY ALKALOSIS 9 0.0055
348 UVEITIS 75 0.0055
349 OESOPHAGEAL CANDIDIASIS 22 0.0055
350 BRAIN DEATH 17 0.0055
351 NOSOCOMIAL INFECTION 12 0.0054
352 NEPHRITIS 18 0.0054
353 CENTRAL NERVOUS SYSTEM LESION 74 0.0054
354 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 292 0.0053
355 RESPIRATORY FAILURE 388 0.0053
356 STUPOR 17 0.0053
357 HYPERTRANSAMINASAEMIA 36 0.0052
358 SPLENOMEGALY 60 0.0051
359 ABDOMINAL INFECTION 13 0.0051
360 PREMATURE DELIVERY 81 0.0051
361 HERPES SIMPLEX 33 0.0051
362 NEUTROPENIC SEPSIS 36 0.0050
363 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 13 0.0050
364 LIVER TRANSPLANT REJECTION 9 0.0050
365 CEREBRAL VENOUS THROMBOSIS 9 0.0050
366 MENINGITIS 33 0.0049
367 AORTIC VALVE INCOMPETENCE 21 0.0049
368 LUNG OPACITY 13 0.0049
369 HYPOGAMMAGLOBULINAEMIA 32 0.0049
370 HEPATIC CYTOLYSIS 62 0.0049
371 STREPTOCOCCAL INFECTION 27 0.0048
372 INTRAOCULAR PRESSURE INCREASED 62 0.0048
373 OTITIS MEDIA 16 0.0048
374 LEUKOPENIA 241 0.0048
375 PANCYTOPENIA 268 0.0048
376 KIDNEY TRANSPLANT REJECTION 23 0.0048
377 ISCHAEMIA 22 0.0048
378 HEPATIC NECROSIS 18 0.0048
379 CEREBRAL HAEMATOMA 16 0.0048
380 HYPOALBUMINAEMIA 37 0.0048
381 ESCHERICHIA BACTERAEMIA 11 0.0047
382 HEPATIC FIBROSIS 16 0.0047
383 ENCEPHALOPATHY 114 0.0046
384 PARADOXICAL DRUG REACTION 17 0.0046
385 HAEMODYNAMIC INSTABILITY 35 0.0046
386 RENAL TUBULAR ACIDOSIS 10 0.0046
387 PNEUMONIA BACTERIAL 42 0.0046
388 PNEUMATOSIS INTESTINALIS 13 0.0046
389 COAGULOPATHY 75 0.0045
390 PNEUMOCYSTIS JIROVECI PNEUMONIA 10 0.0045
391 TACHYPNOEA 61 0.0045
392 MYCOBACTERIUM AVIUM COMPLEX INFECTION 12 0.0045
393 BLOOD CREATININE DECREASED 14 0.0045
394 TORSADE DE POINTES 35 0.0045
395 PULMONARY ALVEOLAR HAEMORRHAGE 25 0.0045
396 BONE MARROW FAILURE 90 0.0044
397 INTRAVENTRICULAR HAEMORRHAGE 11 0.0044
398 PANCREATITIS NECROTISING 10 0.0043
399 SHOCK 100 0.0043
400 EPSTEIN-BARR VIRUS INFECTION 27 0.0043
401 HYPERCAPNIA 13 0.0043
402 PULSELESS ELECTRICAL ACTIVITY 18 0.0043
403 NOCARDIOSIS 11 0.0043
404 C-REACTIVE PROTEIN INCREASED 156 0.0043
405 PATENT DUCTUS ARTERIOSUS 17 0.0043
406 PULMONARY MASS 61 0.0041
407 HEPATOMEGALY 40 0.0041
408 SEPSIS 453 0.0041
409 RENAL IMPAIRMENT 337 0.0040
410 FEBRILE BONE MARROW APLASIA 17 0.0040
411 METABOLIC ENCEPHALOPATHY 12 0.0040
412 NEUROTOXICITY 70 0.0040
413 PAPILLOEDEMA 18 0.0040
414 VASCULAR DEVICE INFECTION 18 0.0040
415 IMMUNOSUPPRESSION 35 0.0040
416 BACTERIAL INFECTION 74 0.0040
417 GENERALISED OEDEMA 49 0.0040
418 SERUM SICKNESS 11 0.0039
419 DRUG LEVEL ABOVE THERAPEUTIC 18 0.0039
420 ENDOTRACHEAL INTUBATION 11 0.0039
421 CHOLESTASIS 75 0.0039
422 PNEUMOCYSTIS JIROVECII PNEUMONIA 39 0.0039
423 BILIRUBIN CONJUGATED INCREASED 9 0.0038
424 HAEMOLYTIC ANAEMIA 34 0.0038
425 BLOOD ALBUMIN DECREASED 30 0.0038
426 DRUG-INDUCED LIVER INJURY 118 0.0038
427 LONG QT SYNDROME 9 0.0037
428 CHOLECYSTITIS 44 0.0037
429 THERAPY NON-RESPONDER 165 0.0037
430 HEMIPARESIS 62 0.0037
431 PNEUMOTHORAX 58 0.0037
432 SPINAL OSTEOARTHRITIS 32 0.0036
433 ORGANISING PNEUMONIA 18 0.0036
434 GAMMA-GLUTAMYLTRANSFERASE INCREASED 80 0.0036
435 STEM CELL TRANSPLANT 9 0.0036
436 SKIN MASS 24 0.0036
437 THROMBOTIC MICROANGIOPATHY 35 0.0036
438 STAPHYLOCOCCAL INFECTION 118 0.0036
439 CUTANEOUS VASCULITIS 13 0.0036
440 GASTROINTESTINAL TOXICITY 17 0.0035
441 LEUKOENCEPHALOPATHY 13 0.0035
442 BREAST CANCER METASTATIC 37 0.0034
443 AUTOIMMUNE THYROIDITIS 13 0.0034
444 PARTIAL SEIZURES 18 0.0034
445 PORTAL VEIN THROMBOSIS 11 0.0034
446 HYPOMAGNESAEMIA 47 0.0034
447 HYPERLACTACIDAEMIA 9 0.0034
448 VENTRICULAR FIBRILLATION 37 0.0033
449 HEPATITIS CHOLESTATIC 20 0.0033
450 METABOLIC ACIDOSIS 106 0.0033
451 HYPERPYREXIA 14 0.0033
452 ARTERIOSCLEROSIS 31 0.0033
453 ORAL FUNGAL INFECTION 9 0.0033
454 PULMONARY TUBERCULOSIS 14 0.0033
455 ACUTE MYELOID LEUKAEMIA 51 0.0033
456 DERMAL CYST 8 0.0033
457 LYMPHOPENIA 46 0.0032
458 TREATMENT FAILURE 267 0.0032
459 SHOCK HAEMORRHAGIC 26 0.0032
460 STEVENS-JOHNSON SYNDROME 71 0.0032
461 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
462 LOW BIRTH WEIGHT BABY 25 0.0031
463 THROMBOPHLEBITIS 11 0.0031
464 ORAL CANDIDIASIS 41 0.0031
465 NEUTROPENIA 422 0.0031
466 MALABSORPTION 16 0.0031
467 RENAL TUBULAR NECROSIS 30 0.0031
468 HYPERNATRAEMIA 15 0.0030
469 HEPATIC LESION 13 0.0030
470 ACUTE KIDNEY INJURY 460 0.0030
471 CYTOKINE RELEASE SYNDROME 60 0.0030
472 ORGAN FAILURE 12 0.0030
473 ILEUS 37 0.0030
474 ATRIOVENTRICULAR BLOCK 23 0.0030
475 BLOOD BILIRUBIN INCREASED 80 0.0030
476 WOUND DEHISCENCE 10 0.0030
477 PREMATURE BABY 89 0.0030
478 HYPERACUSIS 11 0.0030
479 THROMBOCYTOPENIA 330 0.0029
480 CEREBRAL INFARCTION 72 0.0029
481 ENTEROCOLITIS 17 0.0029
482 CIRCULATORY COLLAPSE 50 0.0029
483 HAEMOPTYSIS 81 0.0029
484 HEPATIC FAILURE 87 0.0029
485 RESPIRATORY DISORDER 86 0.0029
486 SWELLING OF EYELID 18 0.0029
487 ACUTE RESPIRATORY FAILURE 55 0.0029
488 SERUM FERRITIN INCREASED 15 0.0028
489 BLOOD CREATININE INCREASED 184 0.0028
490 VITAMIN D DECREASED 24 0.0028
491 RESPIRATORY ACIDOSIS 11 0.0028
492 PLEURAL EFFUSION 169 0.0028
493 ABSCESS 44 0.0028
494 DISEASE PROGRESSION 325 0.0027
495 LARGE INTESTINE POLYP 19 0.0027
496 PERIPHERAL SENSORY NEUROPATHY 16 0.0027
497 PARONYCHIA 12 0.0027
498 RESPIRATORY DISTRESS 75 0.0027
499 SUBCUTANEOUS ABSCESS 13 0.0027
500 CYTOLYTIC HEPATITIS 9 0.0027
501 PRODUCT PRESCRIBING ISSUE 59 0.0027
502 HEPATIC FUNCTION ABNORMAL 101 0.0027
503 PERIORBITAL OEDEMA 14 0.0027
504 ENTERITIS 17 0.0027
505 HEMIPLEGIA 22 0.0026
506 RENAL CYST 21 0.0026
507 AGRANULOCYTOSIS 49 0.0026
508 CONDITION AGGRAVATED 798 0.0026
509 VENTRICULAR SEPTAL DEFECT 15 0.0026
510 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
511 UROSEPSIS 24 0.0026
512 VISUAL ACUITY REDUCED 86 0.0026
513 PURULENT DISCHARGE 11 0.0026
514 PERFORMANCE STATUS DECREASED 12 0.0026
515 PNEUMONITIS 70 0.0026
516 ANURIA 22 0.0026
517 THROMBOTIC THROMBOCYTOPENIC PURPURA 9 0.0026
518 GENERAL PHYSICAL HEALTH DETERIORATION 294 0.0025
519 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
520 DEVICE RELATED INFECTION 39 0.0025
521 TRANSAMINASES INCREASED 56 0.0025
522 AZOTAEMIA 10 0.0025
523 BLOOD CREATINE INCREASED 11 0.0025
524 ADRENAL INSUFFICIENCY 30 0.0025
525 HYPOXIA 87 0.0025
526 BLOOD POTASSIUM INCREASED 40 0.0025
527 HYPERKALAEMIA 86 0.0024
528 BODY TEMPERATURE INCREASED 50 0.0024
529 BASAL CELL CARCINOMA 38 0.0024
530 HYPERURICAEMIA 10 0.0024
531 DRUG INEFFECTIVE 3186 0.0024
532 ASCITES 71 0.0024
533 ACUTE HEPATIC FAILURE 33 0.0024
534 RETINAL HAEMORRHAGE 17 0.0024
535 RASH MACULO-PAPULAR 53 0.0024
536 RENAL FAILURE ACUTE 100 0.0024
537 CARDIOTOXICITY 21 0.0024
538 HYPERCALCAEMIA 29 0.0023
539 JAUNDICE 63 0.0023
540 POLYNEUROPATHY 28 0.0023
541 HEPATOCELLULAR INJURY 33 0.0023
542 ACUTE PULMONARY OEDEMA 13 0.0023
543 CARDIOPULMONARY FAILURE 9 0.0023
544 ELECTROCARDIOGRAM QT PROLONGED 83 0.0023
545 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0023
546 ISCHAEMIC STROKE 41 0.0023
547 CHOLECYSTITIS ACUTE 13 0.0023
548 DRUG INTERACTION 362 0.0023
549 HYPERTHYROIDISM 33 0.0023
550 DRUG TOXICITY 31 0.0023
551 BLOOD UREA INCREASED 38 0.0023
552 RENAL FAILURE 300 0.0023
553 BLOOD ALKALINE PHOSPHATASE INCREASED 56 0.0023
554 ILEUS PARALYTIC 10 0.0022
555 GENERALISED TONIC-CLONIC SEIZURE 37 0.0022
556 CYTOPENIA 27 0.0022
557 BLOOD THYROID STIMULATING HORMONE DECREASED 10 0.0022
558 HAEMOLYSIS 17 0.0022
559 TOOTH INFECTION 29 0.0022
560 MYOPATHY 19 0.0022
561 ARTHRITIS BACTERIAL 9 0.0022
562 PYELONEPHRITIS 19 0.0022
563 ERYSIPELAS 11 0.0022
564 SKIN LESION 59 0.0021
565 PYREXIA 742 0.0021
566 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 22 0.0021
567 CACHEXIA 11 0.0021
568 CEREBRAL ISCHAEMIA 11 0.0021
569 HYDRONEPHROSIS 16 0.0021
570 STATUS EPILEPTICUS 24 0.0021
571 CARDIAC TAMPONADE 10 0.0021
572 HEPATIC STEATOSIS 39 0.0021
573 LIPASE INCREASED 16 0.0021
574 HYPOVOLAEMIC SHOCK 10 0.0021
575 UPPER GASTROINTESTINAL HAEMORRHAGE 35 0.0021
576 BLOOD URIC ACID INCREASED 12 0.0021
577 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
578 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
579 PHOTOSENSITIVITY REACTION 34 0.0021
580 PRODUCT USE IN UNAPPROVED INDICATION 509 0.0021
581 EMBOLISM 17 0.0020
582 PANCREATITIS ACUTE 46 0.0020
583 TUMOUR LYSIS SYNDROME 18 0.0020
584 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 12 0.0020
585 AUTOIMMUNE HEPATITIS 14 0.0020
586 CEREBRAL HAEMORRHAGE 72 0.0020
587 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
588 VENTRICULAR TACHYCARDIA 33 0.0020
589 HALLUCINATION, VISUAL 42 0.0020
590 URINE ABNORMALITY 9 0.0020
591 ACIDOSIS 15 0.0020
592 CARDIAC FAILURE ACUTE 13 0.0019
593 GRAND MAL CONVULSION 18 0.0019
594 MENTAL STATUS CHANGES 54 0.0019
595 DISEASE RECURRENCE 91 0.0019
596 HAEMODIALYSIS 16 0.0019
597 HYPOPHOSPHATAEMIA 14 0.0019
598 RALES 11 0.0019
599 HYPONATRAEMIA 106 0.0019
600 PULMONARY OEDEMA 84 0.0019
601 LIVER INJURY 46 0.0019
602 LUNG INFECTION 29 0.0019
603 RESTLESSNESS 68 0.0019
604 LIVER FUNCTION TEST ABNORMAL 54 0.0019
605 HYPOCALCAEMIA 35 0.0018
606 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 16 0.0018
607 EYE PAIN 102 0.0018
608 ALANINE AMINOTRANSFERASE INCREASED 110 0.0018
609 BLOOD PRESSURE FLUCTUATION 43 0.0018
610 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
611 GASTROENTERITIS 26 0.0018
612 METASTASES TO LYMPH NODES 12 0.0018
613 CHOLANGITIS 11 0.0018
614 PERICARDIAL EFFUSION 41 0.0018
615 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
616 FACIAL PARALYSIS 15 0.0018
617 ASPARTATE AMINOTRANSFERASE INCREASED 93 0.0017
618 ANAEMIA 331 0.0017
619 VASCULITIS 20 0.0017
620 OSTEOMYELITIS 31 0.0017
621 CARDIAC ARREST 140 0.0017
622 PURPURA 15 0.0017
623 HAEMORRHOIDS 33 0.0017
624 DIALYSIS 24 0.0017
625 HAEMATOTOXICITY 16 0.0017
626 POLYP 11 0.0017
627 HAEMORRHAGE INTRACRANIAL 25 0.0017
628 EPILEPSY 51 0.0017
629 NERVOUS SYSTEM DISORDER 52 0.0017
630 BEHAVIOUR DISORDER 9 0.0017
631 TYPE 1 DIABETES MELLITUS 10 0.0017
632 BRADYCARDIA 88 0.0017
633 LEFT VENTRICULAR DYSFUNCTION 11 0.0016
634 NO THERAPEUTIC RESPONSE 20 0.0016
635 ORAL DISORDER 12 0.0016
636 MOUTH HAEMORRHAGE 12 0.0016
637 OFF LABEL USE 1432 0.0016
638 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
639 BREATH SOUNDS ABNORMAL 8 0.0016
640 RED BLOOD CELL COUNT DECREASED 46 0.0016
641 TACHYCARDIA 142 0.0016
642 RESTLESS LEGS SYNDROME 29 0.0016
643 SQUAMOUS CELL CARCINOMA 15 0.0016
644 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41 0.0016
645 SKIN TOXICITY 9 0.0016
646 MITRAL VALVE INCOMPETENCE 18 0.0016
647 DELIRIUM 55 0.0016
648 PERONEAL NERVE PALSY 9 0.0016
649 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 13 0.0016
650 INFECTION 227 0.0016
651 HEPATITIS ACUTE 10 0.0015
652 THERAPY PARTIAL RESPONDER 24 0.0015
653 ATAXIA 18 0.0015
654 HAEMATOCRIT DECREASED 30 0.0015
655 ODYNOPHAGIA 9 0.0015
656 HEPATITIS B 9 0.0015
657 CARDIOMYOPATHY 22 0.0015
658 RHINITIS 12 0.0015
659 HYPOTHERMIA 15 0.0015
660 IMMUNODEFICIENCY 22 0.0015
661 SUBARACHNOID HAEMORRHAGE 15 0.0015
662 HYPERGLYCAEMIA 53 0.0015
663 MYELODYSPLASTIC SYNDROME 21 0.0015
664 LIVER DISORDER 64 0.0014
665 HYPOTENSION 289 0.0014
666 DIFFUSE LARGE B-CELL LYMPHOMA 11 0.0014
667 MUSCLE ATROPHY 18 0.0014
668 MYELOSUPPRESSION 51 0.0014
669 STOMATITIS 85 0.0014
670 HEPATIC ENZYME INCREASED 95 0.0014
671 PRESYNCOPE 33 0.0014
672 COVID-19 PNEUMONIA 16 0.0014
673 HAEMOGLOBIN DECREASED 139 0.0014
674 BLOOD CALCIUM DECREASED 15 0.0013
675 POSTOPERATIVE WOUND INFECTION 9 0.0013
676 BLOOD SODIUM DECREASED 25 0.0013
677 LEUKOCYTOSIS 24 0.0013
678 OPTIC NEURITIS 12 0.0013
679 TREATMENT NONCOMPLIANCE 72 0.0013
680 ECCHYMOSIS 9 0.0013
681 HYPERTHERMIA 10 0.0013
682 RESPIRATORY DEPRESSION 16 0.0013
683 RETINAL DETACHMENT 12 0.0013
684 LIVER FUNCTION TEST INCREASED 28 0.0013
685 PULMONARY HYPERTENSION 27 0.0013
686 CARDIO-RESPIRATORY ARREST 54 0.0013
687 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
688 ARRHYTHMIA 61 0.0013
689 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
690 PNEUMONIA 406 0.0013
691 RENAL INJURY 37 0.0012
692 LYMPHADENOPATHY 44 0.0012
693 VITAMIN D DEFICIENCY 12 0.0012
694 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
695 CHOLELITHIASIS 40 0.0012
696 ANKYLOSING SPONDYLITIS 16 0.0012
697 COMA 57 0.0012
698 EXPOSURE DURING PREGNANCY 74 0.0012
699 CONJUNCTIVITIS 22 0.0012
700 CARDIOGENIC SHOCK 17 0.0012
701 SKIN HYPERPIGMENTATION 10 0.0012
702 PERITONITIS 24 0.0012
703 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
704 PROTEINURIA 22 0.0012
705 CARDIAC MURMUR 10 0.0012
706 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
707 FOETAL EXPOSURE DURING PREGNANCY 93 0.0011
708 ATRIAL FIBRILLATION 111 0.0011
709 CARDIOMEGALY 14 0.0011
710 MYOCARDITIS 13 0.0011
711 AUTOIMMUNE DISORDER 11 0.0011
712 SKIN ULCER 29 0.0011
713 SUBDURAL HAEMATOMA 16 0.0011
714 MYOSITIS 10 0.0011
715 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
716 DECUBITUS ULCER 9 0.0011
717 NEUTROPHIL COUNT DECREASED 45 0.0011
718 LUNG DISORDER 54 0.0011
719 MATERNAL EXPOSURE DURING PREGNANCY 98 0.0011
720 BLOOD POTASSIUM DECREASED 33 0.0011
721 ANAPHYLACTIC SHOCK 28 0.0011
722 CEREBRAL DISORDER 8 0.0011
723 HIATUS HERNIA 14 0.0011
724 PNEUMONIA ASPIRATION 27 0.0011
725 EOSINOPHIL COUNT INCREASED 9 0.0011
726 RESPIRATORY TRACT INFECTION 28 0.0011
727 HEPATIC ENCEPHALOPATHY 10 0.0011
728 DIARRHOEA HAEMORRHAGIC 10 0.0011
729 SKIN INFECTION 12 0.0011
730 SINUS TACHYCARDIA 15 0.0011
731 HEPATITIS 27 0.0011
732 PRODUCT USE ISSUE 198 0.0011
733 TRANSFUSION 11 0.0010
734 OXYGEN SATURATION DECREASED 59 0.0010
735 FOLLICULITIS 11 0.0010
736 BLOOD MAGNESIUM DECREASED 9 0.0010
737 ATELECTASIS 10 0.0010
738 INTERSTITIAL LUNG DISEASE 50 0.0010
739 CHILLS 121 0.0010
740 URINE OUTPUT DECREASED 9 0.0010
741 NEURALGIA 25 0.0010
742 EOSINOPHILIA 18 0.0010
743 ANOREXIA 13 0.0010
744 FEAR 27 0.0010
745 OEDEMA PERIPHERAL 122 0.0010
746 BLISTER 56 0.0010
747 MALNUTRITION 11 0.0010
748 GASTROINTESTINAL DISORDER 88 0.0010
749 BRONCHOSPASM 14 0.0010
750 GASTROINTESTINAL HAEMORRHAGE 81 0.0010
751 FLUID OVERLOAD 14 0.0010
752 PLATELET COUNT DECREASED 102 0.0010
753 LEUKAEMIA 9 0.0010
754 CELLULITIS 48 0.0010
755 MOUTH ULCERATION 20 0.0009
756 HERPES ZOSTER 54 0.0009
757 TOXICITY TO VARIOUS AGENTS 158 0.0009
758 OESOPHAGITIS 10 0.0009
759 OSTEONECROSIS 30 0.0009
760 CARDIAC FAILURE 73 0.0009
761 LYMPHOCYTE COUNT DECREASED 16 0.0009
762 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64 0.0009
763 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
764 LACTIC ACIDOSIS 29 0.0009
765 INFLAMMATION 46 0.0009
766 HAEMATURIA 30 0.0009
767 VENTRICULAR EXTRASYSTOLES 9 0.0009
768 OEDEMA 47 0.0009
769 HYPOGLYCAEMIA 42 0.0009
770 BLINDNESS 35 0.0009
771 METASTASES TO CENTRAL NERVOUS SYSTEM 11 0.0009
772 HAEMORRHAGE 89 0.0009
773 BLINDNESS UNILATERAL 12 0.0008
774 VERTIGO 51 0.0008
775 INTENTIONAL PRODUCT USE ISSUE 72 0.0008
776 MELAENA 18 0.0008
777 COLITIS 31 0.0008
778 SWELLING FACE 53 0.0008
779 ACUTE MYOCARDIAL INFARCTION 24 0.0008
780 RASH PAPULAR 18 0.0008
781 WHITE BLOOD CELL COUNT DECREASED 87 0.0008
782 PANCREATITIS 42 0.0008
783 BLOOD TEST ABNORMAL 11 0.0008
784 LYMPHOMA 12 0.0008
785 RENAL DISORDER 36 0.0008
786 DYSPHAGIA 73 0.0008
787 SPINAL FRACTURE 15 0.0007
788 DRUG ERUPTION 13 0.0007
789 THROMBOSIS 59 0.0007
790 ASPIRATION 8 0.0007
791 DRUG INTOLERANCE 70 0.0007
792 NIGHT SWEATS 23 0.0007
793 FACE OEDEMA 12 0.0007
794 HYPOPHAGIA 18 0.0007
795 CYANOSIS 11 0.0007
796 INFUSION RELATED REACTION 46 0.0007
797 HYPERTENSION 147 0.0007
798 DIPLOPIA 18 0.0007
799 HALLUCINATION, AUDITORY 11 0.0007
800 RESPIRATORY ARREST 19 0.0007
801 BRONCHITIS 51 0.0007
802 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 16 0.0007
803 GASTRIC ULCER 13 0.0007
804 IMMUNE SYSTEM DISORDER 9 0.0007
805 DEHYDRATION 88 0.0007
806 THERAPEUTIC RESPONSE DECREASED 40 0.0007
807 CYSTITIS 21 0.0007
808 URINARY RETENTION 22 0.0007
809 CHRONIC KIDNEY DISEASE 50 0.0007
810 DISORIENTATION 26 0.0007
811 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
812 SKIN REACTION 9 0.0006
813 SINUSITIS 65 0.0006
814 BLOOD PRESSURE DECREASED 42 0.0006
815 HAEMATEMESIS 16 0.0006
816 PRESCRIBED OVERDOSE 12 0.0006
817 VOMITING 289 0.0006
818 RHABDOMYOLYSIS 25 0.0006
819 ANGINA PECTORIS 17 0.0006
820 PULMONARY EMBOLISM 56 0.0006
821 TOOTH DISORDER 13 0.0006
822 ABDOMINAL PAIN 134 0.0006
823 VIRAL INFECTION 19 0.0006
824 GASTRITIS 15 0.0006
825 SWELLING 53 0.0006
826 EAR INFECTION 15 0.0006
827 CONVULSION 32 0.0006
828 GASTROENTERITIS VIRAL 10 0.0006
829 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
830 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
831 AGITATION 40 0.0005
832 HALLUCINATION 41 0.0005
833 VISUAL IMPAIRMENT 67 0.0005
834 HAEMATOMA 14 0.0005
835 PHOTOPHOBIA 10 0.0005
836 RASH MACULAR 18 0.0005
837 CARDIOVASCULAR DISORDER 13 0.0005
838 EPISTAXIS 38 0.0005
839 DYSARTHRIA 19 0.0005
840 INTESTINAL OBSTRUCTION 19 0.0005
841 DEAFNESS 13 0.0005
842 APHASIA 15 0.0005
843 TASTE DISORDER 10 0.0005
844 CONFUSIONAL STATE 79 0.0005
845 MALIGNANT NEOPLASM PROGRESSION 50 0.0005
846 CHROMATURIA 11 0.0005
847 DIABETES MELLITUS 37 0.0005
848 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
849 SKIN DISORDER 16 0.0005
850 SEIZURE 55 0.0005
851 COVID-19 83 0.0005
852 DIVERTICULITIS 13 0.0005
853 POST PROCEDURAL COMPLICATION 9 0.0005
854 UNRESPONSIVE TO STIMULI 12 0.0005
855 DYSURIA 17 0.0005
856 ORAL HERPES 9 0.0005
857 SKIN FISSURES 9 0.0005
858 COUGH 129 0.0005
859 DIABETIC KETOACIDOSIS 11 0.0005
860 DIARRHOEA 294 0.0005
861 ANAPHYLACTIC REACTION 25 0.0005
862 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
863 MEDICATION ERROR 25 0.0004
864 DECREASED APPETITE 104 0.0004
865 NEUROPATHY PERIPHERAL 42 0.0004
866 PALLOR 12 0.0004
867 RASH ERYTHEMATOUS 21 0.0004
868 HYPOTHYROIDISM 14 0.0004
869 WEIGHT DECREASED 121 0.0004
870 NEOPLASM PROGRESSION 15 0.0004
871 DYSPNOEA 237 0.0004
872 URINARY TRACT INFECTION 71 0.0004
873 URINARY INCONTINENCE 12 0.0004
874 ERYTHEMA 83 0.0004
875 OVERDOSE 85 0.0004
876 DRUG ADMINISTRATION ERROR 12 0.0004
877 SYNCOPE 39 0.0004
878 NAUSEA 306 0.0004
879 HYPERSENSITIVITY 71 0.0004
880 DERMATITIS 8 0.0004
881 DEATH 328 0.0004
882 HAEMATOCHEZIA 21 0.0004
883 TREMOR 62 0.0004
884 LOCALISED INFECTION 9 0.0004
885 MUSCULAR WEAKNESS 42 0.0004
886 SKIN EXFOLIATION 31 0.0004
887 LOSS OF CONSCIOUSNESS 47 0.0004
888 LETHARGY 21 0.0004
889 EYE DISORDER 12 0.0004
890 COGNITIVE DISORDER 17 0.0004
891 SOMNOLENCE 72 0.0004
892 ABDOMINAL DISTENSION 37 0.0004
893 HYPOACUSIS 15 0.0003
894 ECZEMA 18 0.0003
895 OSTEOPOROSIS 14 0.0003
896 LABORATORY TEST ABNORMAL 10 0.0003
897 PRODUCTIVE COUGH 16 0.0003
898 BACK PAIN 77 0.0003
899 WHEEZING 19 0.0003
900 SWOLLEN TONGUE 10 0.0003
901 DYSPNOEA EXERTIONAL 12 0.0003
902 ABDOMINAL PAIN LOWER 8 0.0003
903 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
904 HEADACHE 197 0.0003
905 RASH 134 0.0003
906 PSYCHOTIC DISORDER 9 0.0003
907 IMPAIRED HEALING 10 0.0003
908 ABNORMAL BEHAVIOUR 12 0.0003
909 ACCIDENTAL OVERDOSE 11 0.0003
910 CHEST PAIN 54 0.0003
911 CARDIAC FAILURE CONGESTIVE 23 0.0003
912 CONSTIPATION 62 0.0003
913 NEPHROLITHIASIS 13 0.0003
914 MYALGIA 48 0.0003
915 ILL-DEFINED DISORDER 17 0.0003
916 WEIGHT INCREASED 58 0.0003
917 RASH PRURITIC 14 0.0003
918 BONE PAIN 15 0.0003
919 FLUSHING 26 0.0003
920 HEART RATE INCREASED 25 0.0003
921 INFLUENZA 28 0.0003
922 DEEP VEIN THROMBOSIS 16 0.0002
923 HYPOAESTHESIA 36 0.0002
924 AGGRESSION 12 0.0002
925 INCORRECT DOSE ADMINISTERED 54 0.0002
926 OSTEOARTHRITIS 10 0.0002
927 OCULAR HYPERAEMIA 11 0.0002
928 FLATULENCE 13 0.0002
929 SKIN DISCOLOURATION 10 0.0002
930 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
931 POLLAKIURIA 9 0.0002
932 SLEEP DISORDER 15 0.0002
933 MUSCULOSKELETAL PAIN 11 0.0002
934 DIZZINESS 104 0.0002
935 MENTAL DISORDER 9 0.0002
936 CEREBROVASCULAR ACCIDENT 35 0.0002
937 ANGIOEDEMA 9 0.0002
938 PRURITUS 77 0.0002
939 MYOCARDIAL INFARCTION 34 0.0002
940 ASTHENIA 73 0.0002
941 FATIGUE 151 0.0002
942 DYSPHONIA 11 0.0002
943 DISTURBANCE IN ATTENTION 10 0.0002
944 CATARACT 11 0.0002
945 PRODUCT STORAGE ERROR 16 0.0002
946 PAIN 112 0.0002
947 NO ADVERSE EVENT 33 0.0002
948 GAIT DISTURBANCE 34 0.0002
949 FLUID RETENTION 9 0.0002
950 CHEST DISCOMFORT 18 0.0002
951 VISION BLURRED 24 0.0002
952 CARDIAC DISORDER 16 0.0002
953 ASTHMA 19 0.0002
954 MALAISE 73 0.0002
955 PARAESTHESIA 26 0.0002
956 BLOOD PRESSURE INCREASED 25 0.0002
957 HYPERHIDROSIS 21 0.0002
958 BALANCE DISORDER 14 0.0002
959 RHINORRHOEA 10 0.0002
960 PAIN IN EXTREMITY 45 0.0002
961 UNDERDOSE 11 0.0002
962 ABDOMINAL PAIN UPPER 31 0.0002
963 INSOMNIA 40 0.0002
964 PALPITATIONS 17 0.0001
965 FALL 46 0.0001
966 URTICARIA 23 0.0001
967 DEPRESSION 31 0.0001
968 NEOPLASM MALIGNANT 9 0.0001
969 ACNE 10 0.0001
970 OROPHARYNGEAL PAIN 12 0.0001
971 DRY MOUTH 10 0.0001
972 DRUG ABUSE 10 0.0001
973 ADVERSE EVENT 11 0.0001
974 UNEVALUABLE EVENT 9 0.0001
975 ARTHRITIS 9 0.0001
976 MUSCULOSKELETAL STIFFNESS 10 0.0001
977 DYSPEPSIA 11 0.0001
978 ARTHRALGIA 44 0.0001
979 INTENTIONAL PRODUCT MISUSE 9 0.0001
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
981 JOINT SWELLING 11 0.0001
982 ADVERSE DRUG REACTION 8 0.0001
983 ANXIETY 25 0.0001
984 BLOOD GLUCOSE INCREASED 16 0.0001
985 EMOTIONAL DISTRESS 10 0.0001
986 RHEUMATOID ARTHRITIS 9 0.0001
987 PERIPHERAL SWELLING 12 0.0001
988 ABDOMINAL DISCOMFORT 13 0.0001
989 MUSCLE SPASMS 13 0.0001
990 PSORIASIS 9 0.0001
991 ALOPECIA 13 0.0001
992 PRODUCT DOSE OMISSION ISSUE 17 0.0001
993 NASOPHARYNGITIS 9 0.0000
994 FEELING ABNORMAL 10 0.0000